Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patient...
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients
About this item
Full title
Author / Creator
Torriani, Francesca J , Rodriguez-Torres, Maribel , Rockstroh, Jürgen K , Lissen, Eduardo , Gonzalez-García, Juan , Lazzarin, Adriano , Carosi, Giampiero , Sasadeusz, Joseph , Katlama, Christine , Montaner, Julio , Sette, Hoel , Passe, Sharon , De Pamphilis, Jean , Duff, Frank , Schrenk, Uschi Marion , Dieterich, Douglas T and APRICOT Study Group
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this randomized trial involving patients with chronic hepatitis C who were also infected with the human immunodeficiency virus (HIV), peginterferon alfa-2a plus ribavirin was more effective than interferon alfa-2a plus ribavirin or peginterferon alfa-2a plus placebo (rates of sustained virologic response, 40 percent, 12 percent, and 20 percent,...
Alternative Titles
Full title
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients
Authors, Artists and Contributors
Author / Creator
Rodriguez-Torres, Maribel
Rockstroh, Jürgen K
Lissen, Eduardo
Gonzalez-García, Juan
Lazzarin, Adriano
Carosi, Giampiero
Sasadeusz, Joseph
Katlama, Christine
Montaner, Julio
Sette, Hoel
Passe, Sharon
De Pamphilis, Jean
Duff, Frank
Schrenk, Uschi Marion
Dieterich, Douglas T
APRICOT Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_17801102
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17801102
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa040842
